Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

Setback for AZ and BMS as Onglyza flunks cardiovascular trial

Diabetes drug fails to show benefit over placebo

- PMLiVE

BRIC ‘not delivering’ on promises of high growth

Frost & Sullivan report highlights the difficulties for pharma working in BRIC markets

- PMLiVE

Healthwatch England appoints comms and policy directors

Claire Pimm joins from DH and Marc Bush joins from Scope

- PMLiVE

Sanofi and AstraZeneca form cancer research alliances with non-profits

Will work respectively with Curie Institute in France and Cancer Research UK

- PMLiVE

Building BRICs: pharma’s key emerging markets are becoming giants

The BRIC nations – Brazil, Russia, India and China – for so long the leading lights of the emerging markets movement, may soon need to relinquish their 'emerging' tag and...

Kantar Media and Pointlogic unveil comms planning platform

Will determine most appropriate channel for reaching target audiences

- PMLiVE

AbbVie: UK patients want better arthritis care

Study from Humira manufacturer concludes that UK doctors need better collaboration with patients

- PMLiVE

Pay-for-delay deals lead to inflated drug prices says study

Based on analysis of delayed market entry of generic Adderall XR in US

Google ‘aiding and abetting’ illegal online pharmacies

US state attorney general takes issue with auto-complete and ad policies

- PMLiVE

Celgene wins expanded EU approval for cancer drug Revlimid

Approved for use in patients with rare blood disorder

- PMLiVE

Alexion begins work on new global headquarters

Rare diseases drug company will move to new US site in 2015

- PMLiVE

Former UK health secretary joins Bupa board

Patricia Hewitt will serve private health firm as non-executive director

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links